Urologic Oncology: Current Issues and Future Directions
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 460
Special Issue Editors
Interests: kidney cancer; minimally invasive surgery; clinical research; oncological outcomes
Interests: kidney cancer; minimally invasive surgery; reconstructive urology; surgical innovation
Special Issues, Collections and Topics in MDPI journals
Interests: surgery; kidney cancer; robotics; bladder cancer; minimally invasive surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to a Special Issue titled "Urologic Oncology: Current Issues and Future Directions". Urologic oncology represents a critical and dynamic field of medical research and clinical practice. Recent advances in diagnostic techniques, surgical interventions, and targeted therapies have significantly improved patient outcomes in urologic cancers. However, many challenges remain, including the need for early detection, the management of metastatic disease, and the integration of emerging technologies, such as artificial intelligence and precision medicine. This Special Issue aims to consolidate the current knowledge, explore innovative approaches, and chart future directions in the management of urologic malignancies.
This Special Issue aims to gather cutting-edge research and comprehensive reviews that address the complexities and advancements in urologic oncology. By focusing on both current issues and future directions, we seek to provide a platform for early-career and seasoned researchers alike to share their findings and insights. This aligns with the journal's scope of advancing knowledge in the field of urology through the dissemination of high-quality, impactful research. We encourage submissions that span a range of topics within urologic oncology, ensuring a robust and diverse collection of articles that will inform and inspire ongoing and future research efforts.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Innovations in diagnostic imaging for urologic cancers;
- Surgical advancements and minimally invasive techniques;
- Targeted therapies and immunotherapies;
- Genetic and molecular profiling of urologic tumors;
- Management strategies for metastatic urologic cancers;
- The role of artificial intelligence in urologic oncology;
- Patient quality of life and survivorship issues;
- Comparative effectiveness research in urologic oncology;
- Novel biomarkers for early detection and prognosis;
- Precision medicine approaches in urologic oncology.
We look forward to receiving your contributions.
Dr. Riccardo G Bertolo
Prof. Dr. Alessandro Antonelli
Guest Editors
Dr. Francesco Ditonno
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urologic oncology
- diagnostic imaging
- surgical advancements
- targeted therapies
- immunotherapies
- molecular profiling
- artificial intelligence
- quality of life
- biomarkers
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
